drugset / Trial / NCT05427981

Anti-suicidal Effects of Buprenorphine In Depressed Individuals

NCT05427981

RandomizedParallel-groupDouble-blindTreatment

Summary

This study aims to examine the effect of low-dose buprenorphine as an add-on to treatment-as-usual for suicidal ideation in individuals with major depression, and investigate the functional brain activity related to its potential anti-suicidal effect.

Timeline

Start
2022-10-10
Primary completion
2024-01-14
Completion
2024-01-14

Drugs

EvaluationDrugModalityDoseRoute
Subject Buprenorphine Other / unclassified Other